Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neuropace Inc (NQ: NPCE ) 7.430 +0.200 (+2.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 40,707 Open 7.380 Bid (Size) 3.000 (2) Ask (Size) 8.510 (1) Prev. Close 7.230 Today's Range 7.255 - 7.770 52wk Range 5.750 - 18.15 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q2 2024 August 13, 2024 NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga Performance YTD -24.03% -24.03% 1 Month +4.72% +4.72% 3 Month +14.31% +14.31% 6 Month -42.13% -42.13% 1 Year -14.20% -14.20% More News Read More NPCE Stock Earnings: NeuroPace Meets EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 April 17, 2024 From NeuroPace, Inc. Via GlobeNewswire The Latest Analyst Ratings For NeuroPace March 12, 2024 Via Benzinga Recap: NeuroPace Q4 Earnings March 05, 2024 Via Benzinga Earnings Preview: NeuroPace March 04, 2024 Via Benzinga A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts February 22, 2024 Via Benzinga NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) January 30, 2024 Via Benzinga NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q4 2023 March 05, 2024 Via InvestorPlace NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million March 05, 2024 From NeuroPace, Inc. Via GlobeNewswire Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio March 05, 2024 Via InvestorPlace NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference December 19, 2023 From NeuroPace, Inc. Via GlobeNewswire NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration December 04, 2023 From NeuroPace, Inc. Via GlobeNewswire Expert Ratings for NeuroPace December 04, 2023 Via Benzinga Expert Ratings for NeuroPace November 10, 2023 Via Benzinga Earnings Scheduled For March 5, 2024 March 05, 2024 Via Benzinga Breaking Down NeuroPace: 6 Analysts Share Their Views December 27, 2023 Via Benzinga Earnings Scheduled For November 6, 2023 November 06, 2023 Via Benzinga NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting December 01, 2023 From NeuroPace, Inc. Via GlobeNewswire NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference November 21, 2023 From NeuroPace, Inc. Via GlobeNewswire Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position November 10, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session November 06, 2023 Via Benzinga NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance November 06, 2023 From NeuroPace, Inc. Via GlobeNewswire NeuroPace Announces RNS System Enhancements Designed to Streamline Care October 17, 2023 From NeuroPace, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
